Lam Research Co. (NASDAQ:LRCX – Free Report) – Analysts at Zacks Research boosted their Q2 2025 earnings per share (EPS) estimates for Lam Research in a report issued on Wednesday, November 13th. Zacks Research analyst R. Department now anticipates that the semiconductor company will post earnings of $0.87 per share for the quarter, up from their previous forecast of $0.83. The consensus estimate for Lam Research’s current full-year earnings is $3.52 per share. Zacks Research also issued estimates for Lam Research’s Q4 2025 earnings at $0.89 EPS, FY2025 earnings at $3.48 EPS, Q3 2026 earnings at $1.00 EPS, Q4 2026 earnings at $1.10 EPS and Q1 2027 earnings at $1.12 EPS.
Several other equities analysts have also commented on the company. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $100.00 target price on shares of Lam Research in a report on Thursday, October 24th. Needham & Company LLC reaffirmed a “buy” rating and set a $100.00 target price on shares of Lam Research in a report on Thursday, October 24th. Citigroup decreased their price objective on Lam Research from $99.00 to $89.30 and set a “buy” rating for the company in a report on Monday, September 16th. TD Cowen increased their price objective on Lam Research from $100.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. Finally, Stifel Nicolaus reissued a “buy” rating and issued a $100.00 price objective (down from $105.00) on shares of Lam Research in a report on Thursday, October 24th. Seven equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $97.03.
Lam Research Stock Down 6.3 %
NASDAQ:LRCX opened at $70.05 on Monday. The firm has a market capitalization of $90.13 billion, a PE ratio of 22.64, a price-to-earnings-growth ratio of 1.11 and a beta of 1.48. The stock has a 50 day moving average of $77.23 and a 200-day moving average of $87.95. Lam Research has a 52 week low of $68.72 and a 52 week high of $113.00. The company has a current ratio of 2.53, a quick ratio of 1.74 and a debt-to-equity ratio of 0.53.
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its earnings results on Wednesday, October 23rd. The semiconductor company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.81 by $0.05. The company had revenue of $4.17 billion during the quarter, compared to analyst estimates of $4.06 billion. Lam Research had a return on equity of 50.60% and a net margin of 26.02%. The business’s revenue was up 19.7% compared to the same quarter last year. During the same period in the prior year, the company earned $6.85 earnings per share.
Lam Research Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 8th. Shareholders of record on Wednesday, December 11th will be given a $0.23 dividend. The ex-dividend date is Wednesday, December 11th. This represents a $0.92 dividend on an annualized basis and a yield of 1.31%. Lam Research’s dividend payout ratio (DPR) is 29.74%.
Insiders Place Their Bets
In other news, CAO Christina Correia sold 647 shares of the stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $817.51, for a total transaction of $528,928.97. Following the completion of the sale, the chief accounting officer now owns 4,267 shares in the company, valued at approximately $3,488,315.17. This represents a 13.17 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.29% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Lam Research
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Geode Capital Management LLC lifted its position in shares of Lam Research by 2.1% during the 3rd quarter. Geode Capital Management LLC now owns 3,120,511 shares of the semiconductor company’s stock valued at $2,539,413,000 after acquiring an additional 64,053 shares during the last quarter. Savoie Capital LLC lifted its position in shares of Lam Research by 12.2% during the 3rd quarter. Savoie Capital LLC now owns 8,280 shares of the semiconductor company’s stock valued at $6,757,000 after acquiring an additional 900 shares during the last quarter. LRI Investments LLC lifted its position in shares of Lam Research by 667.4% during the 3rd quarter. LRI Investments LLC now owns 2,563 shares of the semiconductor company’s stock valued at $2,092,000 after acquiring an additional 2,229 shares during the last quarter. Groupama Asset Managment raised its stake in Lam Research by 7.8% during the 3rd quarter. Groupama Asset Managment now owns 24,921 shares of the semiconductor company’s stock valued at $203,000 after purchasing an additional 1,810 shares during the period. Finally, Nomura Asset Management Co. Ltd. raised its stake in Lam Research by 67.9% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 189,728 shares of the semiconductor company’s stock valued at $154,833,000 after purchasing an additional 76,752 shares during the period. Institutional investors and hedge funds own 84.61% of the company’s stock.
Lam Research Company Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Featured Stories
- Five stocks we like better than Lam Research
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- High Flyers: 3 Natural Gas Stocks for March 2022
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- ESG Stocks, What Investors Should Know
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.